Global Medicated Confectionery Market Research Report—Forecast till 2026

$4,450$6,250

Global Medicated Confectionery Market is anticipated to witness a significant CAGR of 4.51% to surpass USD 6,861.0 Million during the review period.

Clear

Description

Global Medicated Confectionery Market Research Report—Forecast till 2026
Market Overview
Global Medicated Confectionery Market is anticipated to witness a significant CAGR of 4.51% to surpass USD 6,861.0 Million during the review period. Medicated confectionery consists widely used in the manufacturing of drugs for many conditions such as minor throat irritations, coughs, colds, respiratory tract congestion, and allergies. The major competitors of medicated confectionery are introducing new products and market strategies to gain competitive advantage globally. Additionally, due to the current outbreak of Covid-19, the governments in various countries have ordered the manufacturing of only essential products and medicated confectionery does not fall under essential commodities is expected to limit the market for some extent of time.
Global Medicated Confectionery Market is estimated to register a notable market growth during the review period owing to the rising consumption of confectionery products over the last few years. The global market growth is driven by product inventions based on formulations and innovative packaging. The popularity of medicated confectionery has increased because of the retention time of the dosage form in the oral cavity which bolsters bioavailability, minimizes gastric irritation, and enhances metabolism rate. The rapidly expanding organized retail sector is expected to propel the global medicated confectionery market during the forecast period. However, the rising obesity and diabetes among the consumers are expected to hinder the growth of the global medicated confectionery market during the review period.
Market Segmentation
Global Medicated Confectionery Market by Type, Category, and distribution channel. Based on type segment the global market has been classified into Hard Candies, Soft Confectioneries, Chewing Gums, Gummies & Jellies, Pastilles, and Others. In terms of the Category segment, the market has been bifurcated into Sugar-Based, Sugar-Free.
In terms of distribution channel, the global medicated confectionery market has been categorized into store-based and non-store based. The store-based segment is further divided into supermarkets & hypermarkets, specialty stores, discount stores, and others.
The store-based segment is estimated to lead the global market and reach USD 5,595.6 million during the review period. The non-store-based segment is estimated to exhibit a significant CAGR of 4.59% during 2020-2026.
Regional Analysis
Geographically, the Global Medicated Confectionery Market has been spread across North America, Europe, Asia Pacific, and the Rest of the world.
Asia-Pacific is expected to command the market with a projected CAGR of 4.69% during the review period of 2020 to 2026. In 2019, the region accounted for 41.84% of the global market. China contributes the leading medical confectionery market to the growth of the Asia-Pacific market. The regional market is attributed to the growing organized retail sector in the developing economies of Asia-Pacific during the forecast period
Major Players
The Key players in the global medicated confectionery market are Procter & Gamble Co. (US), Reckitt Benckiser Group PLC (UK), Mondelēz International, Inc. (US), Mars, Incorporated (US), Perfetti Van Mell (Netherlands), Herbion International Inc. (US), LanesHealth (UK), Ricola (Switzerland), Lofthouse of Fleetwood Ltd (UK), Baker Perkins (UK), and UHA Mikakuto (Japan).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 MARKET ATTRACTIVENESS ANALYSIS 14

1.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET, BY PRODUCT TYPE 15

1.1.2 GLOBAL MEDICATED CONFECTIONERY MARKET, BY CATEGORY 16

1.1.3 GLOBAL MEDICATED CONFECTIONERY MARKET, BY DISTRIBUTION CHANNEL 17

1.1.4 GLOBAL MEDICATED CONFECTIONERY MARKET, BY REGION 18

2 MARKET INTRODUCTION
2.1 DEFINITION 19

2.2 SCOPE OF THE STUDY 19

2.3 RESEARCH OBJECTIVE 19

2.4 MARKET STRUCTURE 20

2.5 KEY BUYING CRITERIA 20

3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS 21

3.2 PRIMARY RESEARCH 22

3.3 SECONDARY RESEARCH 23

3.4 MARKET SIZE ESTIMATION 23

3.5 FORECAST MODEL 25

3.6 LIST OF ASSUMPTIONS 26

4 MARKET INSIGHTS
5 MARKET DYNAMICS
5.1 INTRODUCTION 29

5.2 DRIVERS 30

5.2.1 HEALTH BENEFITS ASSOCIATED WITH MEDICATED CONFECTIONERY 30

5.2.2 MOUNTING GROWTH OF ORGANIZED RETAIL SECTOR IN ASIA-PACIFIC REGION 30

5.2.3 DRIVERS IMPACT ANALYSIS 31

5.3 RESTRAINTS 31

5.3.1 INCREASING OBESITY AND DIABETIC PATIENT 31

5.3.2 RESTRAINTS IMPACT ANALYSIS 32

5.4 OPPORTUNITIES 32

5.4.1 INCREASING DEMAND FOR SUGAR-FREE CONFECTIONERY 32

5.4.2 NEW PRODUCT DEVELOPMENT 33

6 MARKET FACTOR ANALYSIS
6.1 VALUE CHAIN ANALYSIS 34

6.1.1 RAW MATERIAL PROCUREMENT 35

6.1.2 PROCESSING 35

6.1.3 PACKAGING 35

6.2 SUPPLY CHAIN ANALYSIS 36

6.3 PORTER’S FIVE FORCES MODEL 37

6.3.1 THREAT OF NEW ENTRANTS 37

6.3.2 BARGAINING POWER OF SUPPLIERS 38

6.3.3 BARGAINING POWER OF BUYERS 38

6.3.4 THREAT OF SUBSTITUTES 38

6.3.5 INTENSITY OF RIVALRY 38

7 IMPACT OF COVID-19 ON THE GLOBAL MEDICATED CONFECTIONARY MARKET
8 GLOBAL MEDICATED CONFECTIONERY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW 41

8.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET ESTIMATES & FORECAST, BY PRODUCT TYPE, 2018–2026 42

8.2 HARD CANDIES 42

8.2.1 HARD CANDIES: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 43

8.3 SOFT CONFECTIONERIES 43

8.3.1 SOFT CONFECTIONERIES: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 44

9 GLOBAL MEDICATED CONFECTIONERY MARKET, BY CATEGORY
9.1 OVERVIEW 45

9.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET ESTIMATES & FORECAST, BY CATEGORY, 2018–2026 46

9.2 SUGAR-BASED 46

9.2.1 SUGAR-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 46

9.3 SUGAR FREE 47

9.3.1 SUGAR FREE: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 47

10 GLOBAL MEDICATED CONFECTIONERY MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW 48

10.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2018–2026 49

10.2 STORE-BASED 49

10.2.1 STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 50

10.3 NON-STORE-BASED 50

10.3.1 NON-STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 50

11 GLOBAL MEDICATED CONFECTIONERY MARKET, BY REGION
11.1 OVERVIEW 51

11.2 NORTH AMERICA 53

11.2.1 US 55

11.2.2 CANADA 57

11.2.3 MEXICO 58

11.3 EUROPE 60

11.3.1 UK 62

11.3.2 GERMANY 64

11.3.3 FRANCE 65

11.3.4 ITALY 67

11.3.5 SPAIN 68

11.3.6 REST OF EUROPE 70

11.4 ASIA-PACIFIC 72

11.4.1 CHINA 74

11.4.2 JAPAN 76

11.4.3 INDIA 77

11.4.4 AUSTRALIA & NEW ZEALAND 79

11.4.5 REST OF ASIA-PACIFIC 80

11.5 REST OF THE WORLD 82

11.5.1 SOUTH AMERICA 84

11.5.2 MIDDLE EAST 86

11.5.3 AFRICA 87

12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION 89

12.1.1 MARKET STRATEGY ANALYSIS 89

12.2 COMPETITIVE BENCHMARKING 90

12.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 91

12.3.1 PRODUCT LAUNCH 91

12.3.2 EXPANSIONS 91

12.3.3 MERGER 91

13 COMPANY PROFILES
13.1 PROCTER & GAMBLE CO. 92

13.1.1 COMPANY OVERVIEW 92

13.1.2 FINANCIAL OVERVIEW 92

13.1.3 PRODUCTS OFFERED 93

13.1.4 KEY DEVELOPMENTS 93

13.1.5 SWOT ANALYSIS 94

13.1.6 KEY STRATEGIES 94

13.2 RECKITT BENCKISER GROUP PLC 95

13.2.1 COMPANY OVERVIEW 95

13.2.2 FINANCIAL OVERVIEW 95

13.2.3 PRODUCTS OFFERED 96

13.2.4 KEY DEVELOPMENTS 96

13.2.5 SWOT ANALYSIS 97

13.2.6 KEY STRATEGIES 97

13.3 MONDELĒZ INTERNATIONAL, INC. 98

13.3.1 COMPANY OVERVIEW 98

13.3.2 FINANCIAL OVERVIEW 98

13.3.3 PRODUCTS OFFERED 99

13.3.4 KEY DEVELOPMENTS 99

13.3.5 SWOT ANALYSIS 100

13.3.6 KEY STRATEGIES 100

13.4 MARS, INCORPORATED 101

13.4.1 COMPANY OVERVIEW 101

13.4.2 FINANCIAL OVERVIEW 101

13.4.3 PRODUCTS OFFERED 101

13.4.4 KEY DEVELOPMENTS 102

13.4.5 SWOT ANALYSIS 102

13.4.6 KEY STRATEGIES 102

13.5 PERFETTI VAN MELL 103

13.5.1 COMPANY OVERVIEW 103

13.5.2 FINANCIAL OVERVIEW 103

13.5.3 PRODUCTS OFFERED 103

13.5.4 KEY DEVELOPMENTS 103

13.5.5 SWOT ANALYSIS 104

13.5.6 KEY STRATEGIES 104

13.6 HERBION INTERNATIONAL INC. 105

13.6.1 COMPANY OVERVIEW 105

13.6.2 FINANCIAL OVERVIEW 105

13.6.3 PRODUCTS OFFERED 105

13.6.4 KEY DEVELOPMENTS 105

13.6.5 KEY STRATEGIES 105

13.7 LANESHEALTH 106

13.7.1 COMPANY OVERVIEW 106

13.7.2 FINANCIAL OVERVIEW 106

13.7.3 PRODUCTS OFFERED 106

13.7.4 KEY DEVELOPMENTS 106

13.7.5 KEY STRATEGIES 106

13.8 RICOLA 107

13.8.1 COMPANY OVERVIEW 107

13.8.2 FINANCIAL OVERVIEW 107

13.8.3 PRODUCTS OFFERED 107

13.8.4 KEY DEVELOPMENTS 107

13.8.5 KEY STRATEGIES 107

13.9 LOFTHOUSE OF FLEETWOOD LTD. 108

13.9.1 COMPANY OVERVIEW 108

13.9.2 FINANCIAL OVERVIEW 108

13.9.3 PRODUCTS OFFERED 108

13.9.4 KEY DEVELOPMENTS 109

13.9.5 KEY STRATEGIES 109

13.10 BAKER PERKINS 110

13.10.1 COMPANY OVERVIEW 110

13.10.2 FINANCIAL OVERVIEW 110

13.10.3 PRODUCTS OFFERED 110

13.10.4 KEY DEVELOPMENTS 110

13.10.5 KEY STRATEGIES 110

13.11 UHA MIKAKUTO 111

13.11.1 COMPANY OVERVIEW 111

13.11.2 FINANCIAL OVERVIEW 111

13.11.3 PRODUCTS OFFERED 111

13.11.4 KEY DEVELOPMENTS 111

13.11.5 KEY STRATEGIES 111

14 REFERENCES

RSS
Follow by Email